NCT03646123 2025-08-28
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Seagen Inc.
Phase 2 Terminated
Seagen Inc.
Eastern Cooperative Oncology Group
Fondazione Michelangelo
University of Cologne
Stanford University
SWOG Cancer Research Network